Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Journal of the Neurological Sciences
|
July 28, 2009
Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial
Joseph M Ferrara, Christopher Kenney, Anthony L Davidson, et al.
The International Journal of Neuroscience
|
September 7, 2013
Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients
Rajeev Kumar, Robert A Hauser, Joseph Mostillo, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
August 5, 2016
Pharmacokinetics and metabolism of [<sup>14</sup>C]-tozadenant (SYN-115), a novel A2a receptor antagonist ligand, in healthy volunteers
Valérie Mancel, François-Xavier Mathy, Pierre Boulanger, et al.
Epilepsia
|
April 19, 2023
Time-to-event clinical trial designs: Existing evidence and remaining concerns
Wesley T Kerr, Stéphane Auvin, Serge Van der Geyten, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 19, 2021
Assessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors
He Zhou, Hung Nguyen, Ana Enriquez, et al.
JAMA Neurology
|
December 13, 2016
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial
Anthony H V Schapira, Susan H Fox, Robert A Hauser, et al.
Epilepsia Open
|
March 7, 2025
Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy
Jacqueline A French, Roger J Porter, Emilio Perucca, et al.
American Journal of Clinical Pathology
|
March 18, 2008
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases
Jing Zhang, Izabela Sokal, Elaine R Peskind, et al.
The Lancet. Neurology
|
July 11, 2014
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
Robert A Hauser, C Warren Olanow, Karl D Kieburtz, et al.
JAMA Neurology
|
October 9, 2023
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial
Jacqueline A French, Roger J Porter, Emilio Perucca, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Journal of the Neurological Sciences
|
July 28, 2009
Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial
Joseph M Ferrara, Christopher Kenney, Anthony L Davidson, et al.
The International Journal of Neuroscience
|
September 7, 2013
Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients
Rajeev Kumar, Robert A Hauser, Joseph Mostillo, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
August 5, 2016
Pharmacokinetics and metabolism of [<sup>14</sup>C]-tozadenant (SYN-115), a novel A2a receptor antagonist ligand, in healthy volunteers
Valérie Mancel, François-Xavier Mathy, Pierre Boulanger, et al.
Epilepsia
|
April 19, 2023
Time-to-event clinical trial designs: Existing evidence and remaining concerns
Wesley T Kerr, Stéphane Auvin, Serge Van der Geyten, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 19, 2021
Assessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors
He Zhou, Hung Nguyen, Ana Enriquez, et al.
JAMA Neurology
|
December 13, 2016
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial
Anthony H V Schapira, Susan H Fox, Robert A Hauser, et al.
Epilepsia Open
|
March 7, 2025
Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy
Jacqueline A French, Roger J Porter, Emilio Perucca, et al.
American Journal of Clinical Pathology
|
March 18, 2008
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases
Jing Zhang, Izabela Sokal, Elaine R Peskind, et al.
The Lancet. Neurology
|
July 11, 2014
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
Robert A Hauser, C Warren Olanow, Karl D Kieburtz, et al.
JAMA Neurology
|
October 9, 2023
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial
Jacqueline A French, Roger J Porter, Emilio Perucca, et al.
Page
of 4